AdvaMed Leaders Discuss Challenges Ahead for Device Industry
Executive Summary
Changes in health care's regulatory landscape could have a negative effect on device innovation. In the following exclusive interview, James Mazzo, newly appointed chairman of the Advanced Medical Technology Association, along with AdvaMed president and CEO Stephen J. Ubl, discuss with Medtech Insight the hurdles facing the medical device industry today.
You may also be interested in...
Health Care Reform: The Excise Tax Was Only the Beginning
The excise tax has been the medical device industry's main concern about pending health care reform, but other changes are taking place that will alter the market and potentially have a greater impact on sales and profits than the 2.3% tax. Specifically, device manufacturers' customers are at the beginning of changes that will alter reimbursement from the CMS to reflect adherence to standards of "best medical practices" tied to quality patient outcomes.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.